Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) published the results of a survey of 12,000 respondents in 11 countries regarding coronavirus vaccination and preferences in vaccine selection. According to the survey results, 73 per cent of the respondents were willing to be vaccinated against the coronavirus, while of those aware of Russia’s Sputnik V vaccine and willing to be vaccinated the number was even higher – four out of every five respondents.

The human adenoviral vector platform, on which the Sputnik V vaccine is based, is almost nine times more reliable than the non-human adenovirus platform.

The survey was conducted from October 9-19, 2020 by YouGov, a leading UK research data and analytics group. It included people from Brazil, Vietnam, Egypt, India, Indonesia, Malaysia, Mexico, Nigeria, UAE, Saudi Arabia and the Philippines.

More than 2.5 billion people live in these countries, or over 30 per cent of the world's population. The survey became one of the largest on this topic and the first global survey involving the countries of the Middle East and Southeast Asia.

The survey was conducted prior to the announcement that the Sputnik V vaccine is 92 per cent effective at protecting people from COVID-19, according to interim trial results.

Key survey results in India

• The overwhelming majority of trial participants are positive about vaccination against the coronavirus (80 per cent of the respondents).
• Among those who are aware of the Russian Sputnik V vaccine, the percentage of those who are willing to be vaccinated is even higher – over 85 per cent of those surveyed.
• 60 per cent of the respondents are aware of Russia’s Sputnik V vaccine – the highest awareness level among the countries that participated in the survey, on par with respondents from Mexico.
• In India, there is high confidence in the human adenovirus vaccine (Sputnik V platform) as nine out of 10 vaccine respondents preferred this platform over non-human adenovirus platforms.
• Russia ranks first among foreign vaccine-manufacturing countries (excluding India), which were mentioned by respondents primarily as the most trustworthy. Overall, five out of 10 respondents said that Russia is one of the most reliable countries (each respondent mentioned three countries).